Evropská unie - čeština - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortison - nedostatek adrenalinu - kortikosteroidy pro systémové použití - substituční léčba adrenální insuficience u kojenců, dětí a dospívajících (od narození do < 18 let).

Evropská unie - čeština - EMA (European Medicines Agency)

taw pharma (ireland) limited - hydrochlorid klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidla - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

strides pharma (cyprus) limited, nicosia array - 2418 metformin-hydrochlorid - tableta s prodlouženým uvolňováním - 750mg - metformin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aspen pharma trading limited, dublin array - 2193 estriol - vaginální kulička - 0,5mg - estriol

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aspen pharma trading limited, dublin array - 1429 testosteron-propionÁt; 1428 testosteron-fenylpropionÁt; 1427 testosteron-isokapronÁt; 9899 testosteron-dekanoÁt - injekční roztok - 250mg/ml - testosteron

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aspen pharma trading limited, dublin array - 2689 thioguanin - tableta - 40mg - thioguanin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aspen pharma trading limited, dublin array - 2193 estriol - vaginální krém - 1mg/g - estriol

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aspen pharma trading limited, dublin array - 1571 melfalan - potahovaná tableta - 2mg - melfalan

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

std pharmaceutical (ireland) limited, dublin array - 1347 natrium-tetradecyl-sulfÁt - injekční roztok - 10mg/ml - natrium-tetradecyl-sulfÁt

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

std pharmaceutical (ireland) limited, dublin array - 1347 natrium-tetradecyl-sulfÁt - injekční roztok - 2mg/ml - natrium-tetradecyl-sulfÁt